"Le centre hospitalier de Roanne, situé au nord-est de la région Rhône Alpes (territoire de santé ouest), est l’hôpital de référence du bassin de santé roannais, qui s’adresse à une population d’environ 150 000 habitants. Le champ de ce bassin couvre la moitié nord du département de la Loire jusqu’à la zone frontalière nord est du département du Rhône, et s’étend sur le sud de la Saône-et-Loire, jusqu’aux environs de Paray-le-Monial. L’hôpital de Roanne constitue aujourd’hui un remarquable outil de travail au service de la population, avec toutes les garanties en termes de confort. Ces rénovations contribuent à une image attractive, renforcée par le rajeunissement récent des équipes de professionnels médicaux et paramédicaux."

During the past decade, Service de Pneumologie; CHG de Roanne conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Service de Pneumologie; CHG de Roanne" #1 collaborator was "Groupe Francais De Pneumo-Cancerologie" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Service de Pneumologie; CHG de Roanne" are "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Non Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Service de Pneumologie; CHG de Roanne" in a lesser frequency.

Most popular intervention types in "Service de Pneumologie; CHG de Roanne" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Alimta®" (1 trials), "Docetaxel" (1 trials), "Erlotinib + docetaxel" (1 trials) and "Taxotere®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Service de Pneumologie; CHG de Roanne" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Service de Pneumologie; CHG de Roanne". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Service de Pneumologie; CHG de Roanne, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Service de Pneumologie; CHG de Roanne, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".